{
    "componentChunkName": "component---node-modules-gatsby-theme-buzzing-src-gatsby-theme-timeline-templates-post-query-js",
    "path": "/en/tweet/1536747867997601793/",
    "result": {"data":{"site":{"siteMetadata":{"title":"纽约时报热门","author":"Buzzing.cc","description":"用中文浏览纽约时报热门报道","keywords":["buzzing","纽约时报"],"siteUrl":"https://nytimes.buzzing.cc","telegram":"@buzzingcc","iconUrl":"https://nytimes.buzzing.cc/avatar.png","defaultSocialImageUrl":"https://images.unsplash.com/photo-1624129591276-5b11185e7b42?ixid=MnwxMjA3fDB8MHxwaG90by1wYWdlfHx8fGVufDB8fHx8&ixlib=rb-1.2.1&auto=format&fit=crop&w=2739&q=80","social":[{"name":"The New York Times","url":"https://www.nytimes.com","external":true},{"name":"Buzzing","url":"https://www.buzzing.cc/","external":true}],"menuLinks":[],"disqus":null,"utterances":null,"localize":[{"title":"The New York Times Trends","description":"See what's buzzing on The New York Times in your native language","keywords":["buzzing","The New York Times"],"locale":"en","social":{"name":null,"url":null,"external":null},"menuLinks":[{"name":"Weekly Selection","url":"/issues","external":null}]},{"title":"紐約時報熱門","description":"用中文瀏覽紐約時報熱門報導","keywords":["buzzing","紐約時報"],"locale":"zh-Hant","social":null,"menuLinks":[]},{"title":"ニューヨーク・タイムズ","description":"人気のニューヨーク・タイムズを日本語で閲覧","keywords":["buzzing","ニューヨーク・タイムズ"],"locale":"ja","social":null,"menuLinks":[]}]}},"blogPost":{"id":"TweetPost-1536747867997601793","excerpt":"","body":"","slug":"/tweet/1536747867997601793/","title":"The FDA on Monday approved a drug that restores hair growth in many alopecia patients. The approval is important for insurance coverage of these expensive drugs, which have a list price of nearly $2,500 a month. https://t.co/4RQPr0DrnH https://t.co/pR8hmVtm0g","tags":["tweet"],"date":"June 14, 2022","dateISO":"2022-06-14T17:55:51.000Z","datetime":"2022-06-14 17:55","image":null,"imageAlt":"Tweet Image","socialImage":null,"__typename":"SocialMediaPost","thirdPartyId":"1536747867997601793","provider":"Twitter","url":"https://twitter.com/nytimes/statuses/1536747867997601793","originalUrl":null,"imageRemote":"https://pbs.twimg.com/media/FVOgCtJXoAEeeFF.jpg","video":null,"channel":null,"channelUrl":null,"author":"The New York Times","authorUrl":"https://twitter.com/nytimes","authorImage":null,"authorImageRemote":"https://pbs.twimg.com/profile_images/1098244578472280064/gjkVMelR.png","authorSlug":"nytimes","score":1057,"views":null,"sharedCount":164,"likeCount":729,"sharedContent":null,"parent":{"localize":[{"locale":"ja","full_text":"FDAは月曜日、多くの脱毛症患者の発毛を回復させる医薬品を承認しました。この承認は、定価が1ヶ月2,500ドル近くするこれらの高価な薬の保険適用にとって重要である。https://t.co/4RQPr0DrnH https://t.co/pR8hmVtm0g。","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh","full_text":"美国食品和药物管理局周一批准了一种能使许多脱发症患者的头发恢复生长的药物。该批准对于这些昂贵药物的保险覆盖率非常重要，这些药物的上市价格每月近2500美元。https://t.co/4RQPr0DrnH https://t.co/pR8hmVtm0g","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh-Hant","full_text":"美國食品和藥物管理局週一批准了一種能使許多脫髮症患者的頭髮恢復生長的藥物。該批准對於這些昂貴藥物的保險覆蓋率非常重要，這些藥物的上市價格每月近2500美元。https://t.co/4RQPr0DrnH https://t.co/pR8hmVtm0g","quoted_status_full_text":null,"retweeted_status_full_text":null}]}},"previous":{"id":"TweetPost-1536689942772035585","excerpt":"","slug":"/tweet/1536689942772035585/","title":"Houston hasn’t ended homelessness, but it shows progress is possible.\n\nThrough cooperation, trust and grinding effort, the city has made remarkable progress moving people from the streets into homes of their own. https://t.co/sk2GLxNOpl","date":"June 14, 2022","__typename":"SocialMediaPost","provider":"Twitter","parent":{"localize":[{"locale":"ja","full_text":"ヒューストンはホームレスをなくしてはいないが、進歩は可能であることを示している。\n\n協力と信頼、そして研鑽によって、ヒューストンは人々を路上から自分の家に移すという目覚しい進歩を遂げた。https://t.co/sk2GLxNOpl","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh","full_text":"休斯顿还没有结束无家可归者，但它表明进步是可能的。\n\n通过合作、信任和磨合努力，该市已经取得了显著的进展，使人们从街头搬到了自己的家中。https://t.co/sk2GLxNOpl","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh-Hant","full_text":"休斯頓還沒有結束無家可歸者，但它表明進步是可能的。\n\n通過合作、信任和磨合努力，該市已經取得了顯著的進展，使人們從街頭搬到了自己的家中。https://t.co/sk2GLxNOpl","quoted_status_full_text":null,"retweeted_status_full_text":null}]}},"next":{"id":"TweetPost-1536721386709852161","excerpt":"","slug":"/tweet/1536721386709852161/","title":"Lizzo, a Grammy-winning singer, changed a lyric on her song “Grrrls” within days of its release after it was criticized for containing a derogatory term for people with disabilities. “This is the result of me listening and taking action,” she said. https://t.co/bvGSvkT0va","__typename":"SocialMediaPost","date":"June 14, 2022","provider":"Twitter","parent":{"localize":[{"locale":"ja","full_text":"グラミー賞受賞歌手のリゾは、自身の曲「Grrrls」の歌詞に障害者蔑視の言葉が含まれていると批判され、発売後数日で歌詞を変更した。「これは、私が耳を傾け、行動を起こした結果です」と彼女は述べています。https://t.co/bvGSvkT0va。","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh","full_text":"格莱美获奖歌手Lizzo在她的歌曲 \"Grrrls \"被批评含有对残疾人的贬义词后，在发布后的几天内修改了这首歌的歌词。\"这是我倾听和采取行动的结果，\"她说。https://t.co/bvGSvkT0va","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh-Hant","full_text":"格萊美獲獎歌手Lizzo在她的歌曲 \"Grrrls \"被批評含有對殘疾人的貶義詞後，在發佈後的幾天內修改了這首歌的歌詞。\"這是我傾聽和採取行動的結果，\"她說。https://t.co/bvGSvkT0va","quoted_status_full_text":null,"retweeted_status_full_text":null}]}}},"pageContext":{"basePath":"/","pageType":"detail","id":"TweetPost-1536747867997601793","previousId":"TweetPost-1536689942772035585","nextId":"TweetPost-1536721386709852161","maxWidth":1024,"siteMetadata":{"siteUrl":"https://nytimes.buzzing.cc","author":"Buzzing.cc","locale":"zh","title":"纽约时报热门","shortTitle":"纽约时报","description":"用中文浏览纽约时报热门报道","keywords":["buzzing","纽约时报"],"telegram":"@buzzingcc","telegram_chat_id":"-1001406368978","iconUrl":"https://nytimes.buzzing.cc/avatar.png","menuLinks":[],"subscriptions":[{"name":"Twitter @buzzingcc","url":"https://twitter.com/buzzingcc","external":true},{"name":"Telegram @buzzingcc","url":"https://t.me/buzzingcc","external":true},{"name":"RSS","url":"/rss.xml","prefetch":false}],"social":[{"name":"The New York Times","url":"https://www.nytimes.com","external":true},{"name":"Buzzing","url":"https://www.buzzing.cc/","external":true}],"localize":[{"locale":"en","title":"The New York Times Trends","shortTitle":"NYTimes","description":"See what's buzzing on The New York Times in your native language","keywords":["buzzing","The New York Times"],"menuLinks":[]},{"locale":"zh-Hant","title":"紐約時報熱門","shortTitle":"紐約時報","description":"用中文瀏覽紐約時報熱門報導","keywords":["buzzing","紐約時報"],"menuLinks":[]},{"locale":"ja","title":"ニューヨーク・タイムズ","shortTitle":"ニューヨーク・タイムズ","description":"人気のニューヨーク・タイムズを日本語で閲覧","keywords":["buzzing","ニューヨーク・タイムズ"],"menuLinks":[]}],"defaultSocialImageUrl":"https://images.unsplash.com/photo-1624129591276-5b11185e7b42?ixid=MnwxMjA3fDB8MHxwaG90by1wYWdlfHx8fGVufDB8fHx8&ixlib=rb-1.2.1&auto=format&fit=crop&w=2739&q=80"},"locale":"en","hrefLang":"en-US","originalPath":"/tweet/1536747867997601793/","dateFormat":"MM/DD/YYYY"}},
    "staticQueryHashes": ["1239077767","2744905544","3280999885"]}